close

A A A
Menu

National Adult Vaccination Program

Article Index

Webinars, Infographics, and Fact Sheets

Fact Sheets

GSA, in collaboration with Gerontological Advanced Practice Nurses Association (GAPNA) and AMDA, has launched a new project focused on improving education and awareness of enhanced influenza vaccine products.

Webinars

Elevating Understanding of RSV in Older Adults
A GSA Webinar
Monday, August 31, 2020 | 12pm - 1pm Eastern
Archived webinar now available.

Respiratory syncytial virus, or RSV, causes 177,000 hospitalizations and 14,000 deaths in older adults each year. Those over 65, adults with chronic heart or lung disease, and adults with weakened immune systems are particularly at risk. Yet RSV remains underdiagnosed.

In this one-hour webinar, experts will share what is known about the prevalence, incidence, and impact of RSV in older adults. Participants will understand the symptoms and differential diagnoses for the disease and identify the reasons for underdiagnoses in older adults. Recent coding changes to improve diagnosis will be discussed, along with specific tips for communication techniques for providers at each phase of interaction with older adults who have RSV.

Speakers:

  • Robin Jump, MD, PhD – Case Western Reserve University, Louis Stokes Cleveland VA Medical Center
  • Lindsay Kim, MD, MPH – Centers for Disease Control and Prevention
  • Helen “Keipp” Talbot, MD, MPH – Vanderbilt University Medical Center

This webinar is supported by Johnson and Johnson Health Systems, Inc. Content is developed by GSA. Contact This email address is being protected from spambots. You need JavaScript enabled to view it. for more information.

Understanding the Value of Enhanced Influenza Vaccine Products in Long-Term Care Settings
A GSA Webinar
Thursday, September 17, 2020 | 1pm - 2pm Eastern 
Free for everyone
Register here.

There are many benefits to preventing flu transmission in long-term care settings yet only about two-thirds of nursing home residents receive annual influenza vaccinations—one of the best known preventive strategies. The COVID-19 pandemic has further amplified the need for effective infection control in these settings. Compared with standard-dose influenza vaccines, enhanced influenza vaccines are not only more effective in preventing disease in older adults, they also provide a higher return on investment. This webinar is designed to help nursing home administrators, infection control teams, and other long-term care staff to (1) understand the benefits of using enhanced influenza vaccine products in residents and (2) learn practical tips that can help leadership and staff consistently apply immunization practices.

Presented by:

  • R. Gordon Douglas, MD, Chair, National Adult Vaccination Program Workgroup; Professor Emeritus, Weill Cornell Medical College (Moderator)
  • David H. Canaday, MD, Professor of Medicine, Case Western Reserve University; Associate Director, Geriatric, Research, Education, and Clinical Center (GRECC), Louis Stokes Cleveland VA Medical Center; Division of Infectious Diseases and HIV Medicine, University Hospitals Cleveland Medical Center
  • Sherry A. Greenberg, PhD, RN, GNP-BC, FGSA, FAANP, FAAN, Associate Professor, Seton Hall University College of Nursing; President-Elect, Gerontological Advanced Practice Nurses Association
  • Barbara Resnick, PhD, RN, CRNP, FAAN, FAANP, Professor, University of Maryland School of Nursing; Co-Director, Biology and Behavior Across the Lifespan Organized Research Center; Sonya Ziporkin Gershowitz Chair in Gerontology

This program was jointly developed by GSA, the Gerontological Advanced Practice Nurses Association, and AMDA – The Society for Post-Acute and Long-Term Care Medicine, with support from Sanofi.

 

Infographics

GSA COVID Combined2

Immunization rates of staff and residents in long-term care facilities are low, even though strategies to improve rates are well known. Leaders gathered at a meeting hosted by GSA in May 2018 to discuss the issue and prioritize actions to improve rates. A shareable PDF is also available.

ltcinfographic

Immune function wanes in all adults—whether healthy or sick—as they age into their fifth decade and beyond. Their bodies become less adept at recognizing and stopping pathogens, and the ability to develop and maintain immunity declines. Also known as immunosenescence, age-related decline in immunity significantly contributes to the susceptibility of older adults to serious conditions, including influenza, pneumonia, and shingles.

The following infographics explain these concepts in easy-to-share formats. See the link below each infographic for a PDF copy. 

Infographic part1 final

 Click here for the PDF copy of Part 1: Immunity As We Age.

Infographic part2 final

 Click here for the PDF copy of Part 2: Shingles - A Case Study in Immunity and Vaccines.

Share This Page!

Print Page